Atenolol vs. Amiloride-Hydrochlorothiazide in the Treatment of Mild to Moderate Hypertension: A Double-Blind,Crossover,Placebo-Controlled Study

Abstract

The antihypertensive effect of atenolol 100 mg was compared to that of amiloride HCl 5 mg + hydrochlorothiazide 50 mg (AHCZ) in a double-blind, crossover, placebo-controlled study of 128 patients. Both drugs were given once daily. Atenolol produced a significant decline in lying, standing, and postexercise blood pressure and pulse rate values. The corresponding values on AHCZ were not significantly different from placebo.

Both the beta-blocking agent and the thiazide diuretic with amiloride were relatively well tolerated. More than half of all adverse effects were nonspecific and also observed in patients on placebo.

In the population studied, atenolol proved to be a superior antihypertensive agent to AHCZ.

MICHAEL LISCHNER, M.D., is Senior Resident, Instructor in Medicine; RUTH LANG, M.D., is Physician, Lecturer in Medicine; ITZHAK JUTRIN, M.D., is Senior Physician; and MORDCHAI RAVID, M.D., is Head, Department of Medicine, Associate Professor of Medicine, Meir Hospital, Kfar Saba, and Tel Aviv University Sackler School of Medicine, Tel Aviv, Israel.

Keywords

amiloride-hydrochlorothiazide atenolol thiazides hypertension

Get full access to this article

View all access options for this article.

References

The Australian therapeutic trial in mild hypertension. Lancet 1980; 1: 1261–7.

Diuretics or betablockers as first-line treatment for mild hypertension (editorial). Lancet 1982; 2: 1316–7.

Veterans Administration cooperative study group on antihypertensive agents: comparison of propanolol and hydrochlorothiazide for the initial treatment of hypertension. I. Results of short term titration with emphasis on racial differences in response. JAMA 1982; 248: 1966–2003.

Veterans Administration cooperative study group on antihypertensive agents: comparison of propanolol and hydrochlorothiazide for the initial treatment of hypertension. II. Results of long term therapy. JAMA 1982; 248: 2004–11.

De Plaen

Vander Elst

Van Yeersele De Strihone

. Penbutolol or hydrochlorothiazide once a day in hypertension. A controlled study with home measurements. Br J Clin Pharmacol 1981; 12: 215–21.

Fegard

Amery

De Plaen

Lijnen

Missotten

. Relative value of beta blockers and thiazides for initiating antihypertensive therapy. Beta blockers or thiazides in hypertension. Acta Cardiol 1977; 31: 411–26.

Weinberger

. Antihypertensive therapy and lipids: evidence, mechanism and implications. Arch Intern Med 1985; 145: 1102–5.

Adverse reaction to bendroflumethiazide and propanolol for the treatment of mild hypertension. Lancet 1981; 2: 539–42.

Petrie

Galloway

Webster

Simpson

Lewis

. Atenolol and bendrofluazide in hypertension. Br Med J 1975; 4: 133–5.

10.

Van Der Veuv

Ten Berge

Donker

AJM

May

Schoorman

Wesseling

. Comparison of hydrochlorothiazide and atenolol as initial treatment in uncomplicated hypertension. Eur J Clin Pharmacol 1984; 26: 157–62.

11.

Gunnels

Jr . Reassessing conventional hypertension treatment. Cardiovasc Rev Rep 1984; 5: 571–2.

12.

Atwood

Gardis

. Diuretics, hypokalemia and ventricular ectopy. The controversy continues. Arch Intern Med 1985; 145: 1185–6.

13.

Helgeland

. Treatment of mild hypertension: a five year controlled drug trial. The Oslo study. Am J Med 1980; 69: 725–32.

14.

Day

Metcalfe

Simpson

. Adrenergic mechanisms in control of plasma lipid concentrations. Br Med J (Clin Res) 1982; 284: 1145–8.